Skip to main content

Please select
your location below

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

By selecting the International view, you verify that you reside outside of the USA and you wish to view DiaSorin Molecular’s International Product Information. This material is intended for International (non-USA) site visitors only.

Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professionaloperators.

NxTAG® Respiratory Pathogen Panel + SARS-CoV-2

Pre-plated, lyophilized reagents facilitate a simple workflow with just one pipetting step, ensuring an easy fit in any lab’s daily routine

Detect 19 viral pathogens, including SARS‑CoV‑2, and three bacterial pathogens in a single well, enabling thorough respiratory health analysis.

Disease state

Respiratory tract infections involve a wide variety of etiologic agents, and present with overlapping signs and symptoms. Prediction of the causative organism based on clinical findings alone is not reliable. The most frequent agents responsible for respiratory infections are respiratory viruses, and then bacteria.  Ensuring accurate detection of causative agents especially in high risk individuals and/or critically ill patients. Reflexing from negative targeted tests to determine unknown causes in ongoing sick individuals is key for appropriate patient management and or isolation.  Panel testing is also highly valuable in determining  respiratory pathogen outbreaks outside winter seasons.

Acute respiratory infection (ARI) is a leading cause of morbidity and mortality worldwide

The value of NxTAG® Respiratory Pathogen Panel + SARS-CoV-2

Empower laboratories with a cost-effective, highly scalable syndromic respiratory panel

Clinical impact

Produce high-quality, trustworthy results for a broad spectrum of pathogens, including SARS-CoV-2. Face rising co-infections and fluctuating etiological agents with proven technology. Guide timely and appropriate treatment decisions for inpatients and high-risk patients.

Outstanding economic value

Inexpensive reagents within a closed tube system reduce total workflow costs and minimize contamination.

Scalable format

A scored 96 sample test plate allows you to run 1 to 96 samples to meet your sample volume and throughput needs.

How the NxTAG® Respiratory Pathogen Panel + SARS-CoV-2 Test works

NxTAG® Respiratory Pathogen Panel + SARS-CoV-2 is a multiplexed in-vitro diagnostic test for the detection and identification of respiratory disease-causing viruses and bacteria from extracted nucleic acid samples.



Add 1-96 extracted sampls to pre-plated test wells containing lypholized reagents.



Integrated multiplex PCR and bead hybridization.



Read on the NxTAG®-Enabled MAGPIX® System.

Indications for NxTAG® Respiratory Pathogen Panel + SARS-CoV-2 use


A qualitative test intended for the simultaneous detection and identification of nucleic acids from multiple respiratory viruses and bacteria extracted from upper respiratory tract specimens


Hospitalized, Emergency Room or outpatient individuals with clinical signs and symptoms of a respiratory tract infection

Use area

Hospital, Public Health or Reference testing laboratories skilled in high-complexity methods

NxTAG® Respiratory Pathogen Panel + SARS-CoV-2

The NxTAG® Respiratory Pathogen Panel technology provides high-quality, trustworthy results for a broad spectrum of pathogens.



Influenza B

Chlamydophila pneumoniae

Coronavirus 229E

Parainfluenza 1

Mycoplasma pneumoniae

Coronavirus HKU1

Parainfluenza 2

Legionella pneumophila

Coronavirus NL63

Parainfluenza 3

Coronavirus OC43

Parainfluenza 4

Human Bocavirus

Respiratory Syncytial Virus A

Human Metapneumovirus

Respiratory Syncytial Virus B

Influenza A


Influenza A – subtype H1


Influenza A – subtype H3

For use with the NxTAG® Enabled MAGPIX® System

The NxTAG® Respiratory Pathogen Panel + SARS-CoV-2 test requires a sample extraction system, RT-PCR capable thermal cycler, and the NxTAG Enabled MAGPIX® instrument to sort and read the hybridized tagged microspheres.

Molecular Diagnostics Tool MAGPIX® System - Diasorin

MAGPIX® System

The simplest, most affordable, and most portable.

Discover more

NxTAG® Respiratory Pathogen Panel + SARS-CoV-2 ordering info

Part Name
Kit Size
Registration Status
Part Number

NxTAG® Respiratory Pathogen Panel + SARS-CoV-2

96 Tests




Diasorin document repository


Luminex document repository

Discover more

Research publications

Discover more

More details about NxTAG® Respiratory Pathogens Panel + SARS-CoV-2

Get in touch

If you need any information about our products, contact our specialists. 

Contact us

Need any help?

Get help with Diasorin products and services.

Ask for support